Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Cigna To Buy Great American Supplemental Benefits For $295 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/11/2012 | 12:28am CET

Cigna Corp. (>> CIGNA Corporation) has agreed to acquire American Financial Group Inc.'s (AFG) Medicare supplement and critical-illness businesses for approximately $295 million in cash, as the managed-care company looks to expand its presence in the individual and seniors markets.

Cigna said its acquisition of Great American Supplemental Benefits Group, one of the largest manufacturers of supplemental health insurance products in the U.S., is expected to close in the second half of 2012.

Great American generated approximately $325 million of revenue last year.

Cigna said the acquisition will expand its individual supplemental offerings to customers in the U.S., bring scaled offerings to the seniors market and extend its direct-to-consumer retail channel.

The deal comes after Cigna bought Medicare carrier HealthSpring Inc. in January for $3.8 billion. The HealthSpring acquisition represented a change in the balance of Cigna, which had primarily focused on employers but will now also be a major source of both Medicare prescription-drug plans and Medicare Advantage coverage, the private insurers' version of the government program.

Cigna has seen its revenue grow in recent quarters, helped by growing membership and a continuing trend of patients using fewer health-care services amid a shaky economy. Last week, the company reported its first-quarter earnings fell 10%, due in part to acquisition costs, though membership growth contributed to better-than-expected revenue.

Meanwhile, American Financial said the deal is expected to be slightly dilutive to its earnings in the short term but will help the company focus on its core businesses.

Cigna shares were up by 11 cents to $45.02 after hours. The stock is up 6.9% so far this year.

-By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; nathalie.tadena@dowjones.com

Stocks mentioned in the article : CIGNA Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
11/30 CIGNA : Launches One Guide – Simplified, Personalized Service to Help Choo..
11/30 CIGNA : Launches One Guide - Simplified, Personalized Service to Help Choose Hea..
11/30DJANTHEM : Begins Defense of Cigna Merger at Antitrust Trial
11/29DJANTHEM : Testimony Shows Anthem and Cigna at Odds Over Proposed Merger -- Update
11/29DJANTHEM : Testimony Shows Anthem and Cigna At Odds Over Proposed Merger
11/28 CIGNA : Offers Holiday Survival Tips as Part of National Health Improvement Tour
11/28 CIGNA CORPORATION (NYSE : CI) Files An 8-K Regulation FD Disclosure
11/28 CIGNA CORP : Regulation FD Disclosure (form 8-K)
11/24 CIGNA : Firefly Value Partners Lp buys $13,500,670 stake in CIGNA Corporation
11/23DJANTHEM-CIGNA ANTITRUST TRIAL : Day Two
More news
Sector news : Managed Healthcare - NEC
11/30DJANTHEM : Begins Defense of Cigna Merger at Antitrust Trial
11/29DJU.S. Stocks Edge Higher
11/29DJANTHEM : Testimony Shows Anthem and Cigna at Odds Over Proposed Merger -- Update
11/29DJUNITEDHEALTH : Gives Upbeat Outlook for 2017
11/29DJANTHEM : Testimony Shows Anthem and Cigna At Odds Over Proposed Merger
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
12/01 UnitedHealth Group's Free Cash Flow Generation Impresses
11/30 What A Hillary Recount Could Mean To You
11/28 Cigna sees non-GAAP operating income of almost $2.1B this year
11/27 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2016 Updat..
11/25 Black Friday (Arb) Bargains
Advertisement
Financials ($)
Sales 2016 39 579 M
EBIT 2016 3 297 M
Net income 2016 1 936 M
Debt 2016 1 292 M
Yield 2016 0,02%
P/E ratio 2016 17,87
P/E ratio 2017 14,19
EV / Sales 2016 0,90x
EV / Sales 2017 0,85x
Capitalization 34 259 M
More Financials
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 150 $
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Mark Marsters Senior Vice President-Group Operations
Thomas A. McCarthy Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION-8.81%34 259
UNITEDHEALTH GROUP INC36.63%152 985
AETNA INC23.46%46 842
ANTHEM INC4.06%38 224
HUMANA INC19.67%31 852
CENTENE CORP-12.43%9 823
More Results